SavedAdd your journal

Journals / Journal of Contemporary Medicine / 2018 / Cilt: 8 - Sayı: 2

Neutrophil to Lymphocyte Ratio and Plateled to Lymphocyte Ratio in Patients with Pulmonary Embolism

Pulmoner Emboli Hastalarında Nötrofil/Lenfosit Oranı ve Trombosit/Lenfosit Oranı

Serdar Savaş GÜL
Nurşah BAŞOL
Pages
111–116
Publication Date
2018-05-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: NLR and PLR values may be a useful biomarker for risk stratification and also prognosis for PE.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of our study was to investigate clinical importance of neutrophil to lymphocyte ratio (NLR) and plateled to lymphocyte ratio (PLR) in patients with acute pulmonary embolism (PE).Methods: 50 patients with a diagnosis of acute PE included into the study between January 2016 and December 2017.
📊
Key Findings & Data:Pre-treatment and post-treatment groups of NLR and PLR values were compared.Results: It has been NLR and PLR ratio have a significantly higher value in admission and patients with pre-treatment groups were found statistically significant variable to predict the treatment effects.
💡
Conclusion & Impact:Conclusion: NLR and PLR values may be a useful biomarker for risk stratification and also prognosis for PE.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:pulmoner emboli · nötrofil/lenfosit oranına · trombosit/lenfosit oranı

Abstract

Objective: The aim of our study was to investigate clinical importance of neutrophil to lymphocyte ratio (NLR) and plateled to lymphocyte ratio (PLR) in patients with acute pulmonary embolism (PE).Methods: 50 patients with a diagnosis of acute PE included into the study between January 2016 and December 2017. NLR level was measured by dividing neutrophil count to lymphocyte count. PLR level was measured by dividing plateled count to lymphocyte count. Pre-treatment and post-treatment groups of NLR and PLR values were compared.Results: It has been NLR and PLR ratio have a significantly higher value in admission and patients with pre-treatment groups were found statistically significant variable to predict the treatment effects. Also, correlation analysis showed a significant correlation between NLR and PLR. Conclusion: NLR and PLR values may be a useful biomarker for risk stratification and also prognosis for PE.

Özet

Amaç: Çalışmanın amacı akut pulmoner embolisi olan hastalarda nötrofil/lenfosit oranının (NLR) ve plateled/lenfosit oranının (PLR) klinik önemini araştırmaktır.Yöntem: Ocak 2016 ile Aralık 2017 tarihleri ​​arasında akut pulmoner emboli tanısı konan 50 hasta çalışmaya dahil edildi. NLR düzeyi, nötrofil sayısının lenfosit sayısına bölünmesiyle ölçüldü. PLR düzeyi, plateled sayısının lenfosit sayımına sayısına bölünmesiyle ölçüldü. NLR ve PLR ​​değerlerinin tedavi öncesi ve tedavi sonrası grupları ile karşılaştırıldı.Bulgular: Başvuruda NLR ve PLR ​​oranı anlamlı olarak yüksekti ve tedavi öncesi grupların tedavi etkilerini tahmin etmek için istatistiksel olarak anlamlı bir değişken olarak bulundu. Ayrıca, NLR ve PLR ​​arasında anlamlı bir korelasyon saptandı. Sonuç: NLR ve PLR ​​düzeyleri tedavi sonrası komorbidite için risk sınıflandırmasında yararlı ve invazif olmayan bir biyobelirteç olabilir.

🔖

Cite This Article

GÜL, S. S., BAŞOL, N. (2018). Neutrophil to Lymphocyte Ratio and Plateled to Lymphocyte Ratio in Patients with Pulmonary Embolism. Journal of Contemporary Medicine, Cilt: 8 - Sayı: 2, 111–116. https://ajindex.com/articles/775353

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Goldhaber S, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 1999;353(9162):1386-9.
  2. Cohen AT, Agnelli G, Anderson FA, Arcelus JI, Bergqvist D, Brecht JG, et al. (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64.
  3. Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. A prediction rule to identify low-risk patients with pulmonary embolism. Arch Intern Med 2006;166:169-75.
  4. Kayrak M, Erdoğan HI, Solak Y, Akilli H, Gül EE, Yildirim O, et al.Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study. Heart Lung Circ 2014;23(1):56-62.
  5. Trujillo-Santos J, Di Micco P, Iannuzzo M, Lecumberri R, Guijarro R, Madridano O, et al. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry. Thromb Haemost 2008;100(5):905-11.
  6. Zhu L, Wang C, Yang YH, Wu YF, Zhai ZG. Prognostic value of right ventricular dysfunction and derivation of a prognostic model for patients with acute pulmonary thromboembolism. Zhonghua Liu Xing Bing Xue Za Zhi 2009;30(2):184-8.
  7. Masotti L, Cappelli R. C-reactive protein in elderly patients with suspected and confirmed pulmonary embolism. Clin Appl Thromb Hemost 2007;13(2):221-3. Zahorec R. Ratio of neutrophil to lymphocyte counts–rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001;102(1):5-14.
  8. Ciofetta G, Piepsz A, Roca I, Fisher S, Hahn K, Sixt R et al.Guidelines for lung scintigraphy in children.Eur J Nucl Med Mol Imaging 2007;34(9):1518-26.
  9. Mahan CE, Borrego ME, Woersching AL, Federici R, Downey R, Tiongson J, et al. Venous thromboembolism: Annualised United States models for total, hospital-acquired and preventable costs utilising long-term attack rates. Thromb Haemost 2012;108:291-302.
  10. Ma Y, Mao Y, He X, Sun Y, Huang S, Qiu J. The values of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting 30 day mortality in patients with acute pulmonary embolism. BMC Cardiovasc Disord 2016;16:123. Konstantinides SV. Trends in incidence versus case fatality rates of pulmonary embolism: Good news or bad news? Thromb Haemost 2016;115:233-5.
  11. Smith SB, Geske JB, Maguire JM, Zane NA, Carter RE, Morgenthaler TI. Early anticoagulation is associated with reduced mortality for acute pulmonary embolis